Microbiome (Jan 2025)

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease

  • Emmanouil Nychas,
  • Andrea Marfil-Sánchez,
  • Xiuqiang Chen,
  • Mohammad Mirhakkak,
  • Huating Li,
  • Weiping Jia,
  • Aimin Xu,
  • Henrik Bjørn Nielsen,
  • Max Nieuwdorp,
  • Rohit Loomba,
  • Yueqiong Ni,
  • Gianni Panagiotou

DOI
https://doi.org/10.1186/s40168-024-01990-y
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Background The pathogenesis of non-alcoholic fatty liver disease (NAFLD) with a global prevalence of 30% is multifactorial and the involvement of gut bacteria has been recently proposed. However, finding robust bacterial signatures of NAFLD has been a great challenge, mainly due to its co-occurrence with other metabolic diseases. Results Here, we collected public metagenomic data and integrated the taxonomy profiles with in silico generated community metabolic outputs, and detailed clinical data, of 1206 Chinese subjects w/wo metabolic diseases, including NAFLD (obese and lean), obesity, T2D, hypertension, and atherosclerosis. We identified highly specific microbiome signatures through building accurate machine learning models (accuracy = 0.845–0.917) for NAFLD with high portability (generalizable) and low prediction rate (specific) when applied to other metabolic diseases, as well as through a community approach involving differential co-abundance ecological networks. Moreover, using these signatures coupled with further mediation analysis and metabolic dependency modeling, we propose synergistic defined microbial consortia associated with NAFLD phenotype in overweight and lean individuals, respectively. Conclusion Our study reveals robust and highly specific NAFLD signatures and offers a more realistic microbiome-therapeutics approach over individual species for this complex disease. Video Abstract

Keywords